OP
NDRM

Omni Partners’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Omni Partners’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,116,596
Closed -$43.4M – 41
2017
Q3 		$43.4M Buy
+1,116,596
New +$41.1M 5.55% 7

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Omni Partners's NDRM Position: Q4 2017 in Review

Omni Partners sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 1,116,596 shares — an estimated $43.4M sold.

Omni Partners first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $43.4M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Omni Partners reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Omni Partners sold 1,116,596 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $43.4M.
  • Omni Partners first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • Omni Partners's NeuroDerm Ltd. Ordinary Shares position peaked at $43.4M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Omni Partners's 13F filing for Q4 2017, filed 22 Jan 2018.